1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Psoriasis Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Psoriasis Market Revenues & Volume, 2022 & 2032F |
3.3 United States (US) Psoriasis Market - Industry Life Cycle |
3.4 United States (US) Psoriasis Market - Porter's Five Forces |
3.5 United States (US) Psoriasis Market Revenues & Volume Share, By Types, 2022 & 2032F |
3.6 United States (US) Psoriasis Market Revenues & Volume Share, By Treatment, 2022 & 2032F |
3.7 United States (US) Psoriasis Market Revenues & Volume Share, By Diagnosis, 2022 & 2032F |
3.8 United States (US) Psoriasis Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.9 United States (US) Psoriasis Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 United States (US) Psoriasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of psoriasis in the United States |
4.2.2 Growing awareness about psoriasis and its treatment options |
4.2.3 Technological advancements in psoriasis treatment and therapies |
4.3 Market Restraints |
4.3.1 High cost of psoriasis medications and treatments |
4.3.2 Side effects associated with current psoriasis treatments |
4.3.3 Lack of reimbursement policies for certain psoriasis therapies |
5 United States (US) Psoriasis Market Trends |
6 United States (US) Psoriasis Market, By Types |
6.1 United States (US) Psoriasis Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Psoriasis Market Revenues & Volume, By Types, 2022-2032F |
6.1.3 United States (US) Psoriasis Market Revenues & Volume, By Nail Psoriasis, 2022-2032F |
6.1.4 United States (US) Psoriasis Market Revenues & Volume, By Guttate Psoriasis, 2022-2032F |
6.1.5 United States (US) Psoriasis Market Revenues & Volume, By Psoriatic Arthritis, 2022-2032F |
6.2 United States (US) Psoriasis Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Psoriasis Market Revenues & Volume, By Tumour necrosis factor inhibitors, 2022-2032F |
6.2.3 United States (US) Psoriasis Market Revenues & Volume, By Vitamin D analogues, 2022-2032F |
6.2.4 United States (US) Psoriasis Market Revenues & Volume, By Interleukin-inhibitors, 2022-2032F |
6.3 United States (US) Psoriasis Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Psoriasis Market Revenues & Volume, By Physical Examination, 2022-2032F |
6.3.3 United States (US) Psoriasis Market Revenues & Volume, By Skin Biopsy, 2022-2032F |
6.4 United States (US) Psoriasis Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Psoriasis Market Revenues & Volume, By Oral, 2022-2032F |
6.4.3 United States (US) Psoriasis Market Revenues & Volume, By Topical, 2022-2032F |
6.5 United States (US) Psoriasis Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Psoriasis Market Revenues & Volume, By Hospital Pharmacy, 2022-2032F |
6.5.3 United States (US) Psoriasis Market Revenues & Volume, By Retail Pharmacy, 2022-2032F |
6.5.4 United States (US) Psoriasis Market Revenues & Volume, By Online Pharmacy, 2022-2032F |
7 United States (US) Psoriasis Market Import-Export Trade Statistics |
7.1 United States (US) Psoriasis Market Export to Major Countries |
7.2 United States (US) Psoriasis Market Imports from Major Countries |
8 United States (US) Psoriasis Market Key Performance Indicators |
8.1 Patient adherence rates to prescribed psoriasis treatments |
8.2 Number of new psoriasis drug approvals by regulatory authorities |
8.3 Percentage of dermatologists adopting novel treatment approaches for psoriasis |
9 United States (US) Psoriasis Market - Opportunity Assessment |
9.1 United States (US) Psoriasis Market Opportunity Assessment, By Types, 2022 & 2032F |
9.2 United States (US) Psoriasis Market Opportunity Assessment, By Treatment, 2022 & 2032F |
9.3 United States (US) Psoriasis Market Opportunity Assessment, By Diagnosis, 2022 & 2032F |
9.4 United States (US) Psoriasis Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.5 United States (US) Psoriasis Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 United States (US) Psoriasis Market - Competitive Landscape |
10.1 United States (US) Psoriasis Market Revenue Share, By Companies, 2025 |
10.2 United States (US) Psoriasis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |